A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)

Trial Profile

A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS)

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Apr 2015

At a glance

  • Drugs Mycophenolate sodium (Primary) ; Calcineurin inhibitors; Mycophenolate mofetil; Prednisone
  • Indications Renal transplant rejection
  • Focus Pharmacokinetics
  • Acronyms AUC-MPA
  • Most Recent Events

    • 01 Apr 2015 According to the ClinicalTrials.gov record, status changed from not yet recruiting to completed.
    • 10 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top